We just filed an amicus brief in the Supreme Court on behalf of 360 repro health researchers explaining why dispensing mifepristone by mail and at pharmacies is safe and backed by science!
Cathren Cohen (she/her)
Today, 360 researchers—led by ANSIRH & @uclarepropolicy.bsky.social—filed an amicus brief in LA v. FDA, urging SCOTUS to follow science & reject restrictions on mifepristone.
Eliminating telehealth by mail & pharmacy would ban safe care for people who need it most. www.ansirh.org/research/res...
This week, the Supreme Court of the United States temporarily restored access to medication abortion pills by mail, pausing a Fifth Circuit ruling in Louisiana v. FDA that had reinstated in-person req...
